Clean Room Requalification
This sits in the lower-middle of the Engineering & Architecture band — a mid-scale opportunity. Based on 33,646 valued Engineering & Architecture tenders in our corpus.
NHS Blood and Transplant publishes Engineering & Architecture work continuously — 21 notices, roughly one every 79 days. This is a stream to watch, not a cycle to wait for.
58% of NHS Blood and Transplant’s awards go to a supplier it has used before.
Which is the argument for getting on the list rather than winning this one. The incumbent is rarely the last winner — it is the roster. See the retention odds by category →
NHS Blood and Transplant (NHSBT) have a requirement for Clean Room Requalification.
The Clinical Biotechnology Centre (CBC) at NHS Blood and Transplant (NHSBT) is a specialist facility that manufactures plasmids and viral vectors for early-stage clinical trials targeting incurable diseases like cancer and genetic disorders.
Operating as part of NHSBT's Cellular and Molecular Therapies function, the CBC supports the UK life sciences sector by translating laboratory research into clinical-grade therapies.
The manufacture of sterile products or tissues should be carried out in clean areas, entry to which is through change rooms/air locks/transfer hatches for personnel/equipment and materials.
These classified environments MUST be monitored and achieve the appropriate current GMP regulatory specifications for that environment as detailed in EudraLex volume 4 “The rules governing medicinal products in the European Union” Annex 1 Manufacture of sterile medicinal products.
Classification and Re-qualification is performed at a minimum annually At Rest, except for particle counts which are performed At Rest and In Operation.
What the notice asks for
The manufacture of sterile products or tissues
The manufacture of sterile products or tissues should be carried out in clean areas, entry to which is through change rooms/air locks/transfer hatches for personnel/equipment and materials.
These classified environments MUST be monitored
These classified environments MUST be monitored and achieve the appropriate current GMP regulatory specifications for that environment as detailed in EudraLex volume 4 “The rules governing medicinal products in the European Union” Annex 1 Manufacture of sterile medicinal products.
Sentences from the notice that state an obligation, surfaced automatically and shown in the order they appear. Not an exhaustive list — always confirm against the tender documents.
Make the case to bid
Reveal who to approach at NHS Blood and Transplant, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
The full intelligence dossier
Our agent reads NHS Blood and Transplant’s accounts, hunts live signals, finds the people who decide — and hands you a bid strategy plus a go-to-market influence plan, including what your team should post this week. You approve every paid step.
Five included while we’re in beta, and the agent asks before it spends on any paid step.
- OCID
- ocds-h6vhtk-06bf4b
- Stage
- planning · Planning
- Source
- Find a Tender
- Buyer ref
- 060844-2026
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Engineering & Architecture
NHS Blood and Transplant’s tender network